Friday Dec 4 | WebMD Health News
Metformin vs. Sulfonylureas for Diabetes
Dec. 4, 2009 -- Concerns that the diabetes drugs Avandia and Actos raise theA risk for heart failure led the FDA to require label changes warning of the potential risk two years ago.
Friday Dec 4 | HIV and Hepatitis
Statin and Diabetes Drug Show Activity against Hepatitis B Virus in Laboratory Studies
SUMMARY: Simvastatin , a medication used to lower blood cholesterol, had a synergistic effect against hepatitis B virus when combined with antiviral drugs in a laboratory study, researchers reported last month at the 60th Annual Meeting of the American Association for the Study of Liver Diseases in Boston.
PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte...
C-Met/HGF/SF signaling is essential for normal embryogenesis, organogenesis, and tissue regeneration.
New research: Commercial Insight: Antidiabetics - DPP-IV inhibitors poised to sweep the market
The growth will be driven by the launch of new drug classes, notably the DPP-IV inhibitors and GLP-1 agonists, and large growth in patient numbers.
Diabetes drugs double women's fracture risk
Long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes, according to a study released on Wednesday.
Oral-lyn vs. Afresa: How Generex Will Beat Mannkind
As biotech companies and large pharma embark on paths to usher in more effective diabetes drugs to market, one of the more significant concerns regarding diabetes related drug development is safety.
Inhibitory effect of evodiamine alone and in combination with...
E-mail: Jcha@yuhs.ac 5 Received 2 June 2009; Revised 31 August 2009; Accepted 7 September 2009; Published online 27 October 2009.
Transcriptional Upregulation of Mitochondrial Uncoupling Protein 2...
From the Center for Translational Research in Biomedical Sciences , Chang Gung Memorial Hospital-Kaohsiung Medical Center; Departments of Medical Education and Research and Neurology , Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China.
Incyte a ' Life After Debt For part I click here On top its JAK programs, Incyte has been developing two additional programs it intends to out-license. The first program is INCB13739 for diabetes, which already reached clinical proof of concept and could be licensed imminently.
Bone Fractures: Symptoms or Side Effects?
Bone fractures are often a symptom of conditions or diseases such as osteoporosis, but could also be side effects associated with certain medications .
Ask the Pharmacist, Richard Hoffman
Q: I heard that a new oral drug for diabetes was approved. What can you tell me about it? A: The FDA recently approved Onglyza for the treatment of people with type 2 diabetes.
Prescription Avandia Has Been Linked To Cases Of Serious Side Effects And Fatalities
The prescription drug Avandia causes an increase in liver problems, heart problems and bone density problems resulting in fractures.
Diabetes drug shows promise in fighting lethal cancer complication
Insulin resistance, the hallmark of type 2 diabetes and a condition often associated with obesity, is paradoxically also an apparent contributor to muscle wasting and severe fat loss that accompanies some cancers, according to new research.
Effect of duodenal-jejunal exclusion in a non-obese animal model of...
Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.
Rapid Breathing, Confusion, and Lethargy: Symptoms or Side Effects?
Rapid breathing, confusion, and lethargy are often symptoms of conditions or diseases such as anxiety or metabolic acidosis, but could also be side effects associated with certain medications .
Research links diabetes drug to more deaths, heart failure
A group of Ontario researchers is calling into question the continued use of the controversial diabetes drug Avandia, saying a competing drug in the same class is as effective and less dangerous.
A Drug Used To Treat Type 2 Diabetes Is Associated To Increased Risk Of Heart Failure
A study just published on bmj.com reports that rosiglitazone, a drug used to treat type 2 diabetes , is linked with an increased risk of heart failure and death among elder patients compared to pioglitazone, which is a similar drug.
Stop prescribing killer diabetes drug, scientists warn
Rosiglitazone, brand name Avandia, has higher rates of heart failure and death than similar alternative Scientists say doctors should stop prescribing a commonly used diabetes drug, after studies show that it is linked to higher rates of heart failure and death than a similar alternative.
Diabetes Drug Linked To Increased Risk Of Heart Failure
Main Category: Diabetes Also Included In: Heart Disease ; Cardiovascular / Cardiology Article Date: 19 Aug 2009 - 13:00 PDT Rosiglitazone, a drug used to treat type 2 diabetes , is associated with an increased risk of heart failure and death among older patients compared to a similar drug , concludes a study published on bmj.com today.
Diabetes drug linked to increased risk of heart failure
Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug , concludes a study published on bmj.com today.
Also on Topix